AbstractViral Hepatitis and Liver DiseaseHIVRSVTuberculosisAPACC 2021Immune profile of COVID-19 patients treated with corticosteroids vs anti-interleukin 6 {tocilizumab) for cytokine release syndrome.View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Association between the levels of serum free testosterone levels and lifestyle-related diseases in people living with HIVView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Amnestic Neurocognitive Impairment in Older Adults Living with HIV with Immune Recovery Following Delayed Antiretroviral Treatment in Northern ThailandView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Clinical case presentation: A preliminary profile of common co-morbidities and risk practices in a sample of HIV/HCV co-infected patients in Puerto RicoView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically suppressed HIV-1 infected adult subjects harboring the NRTI resistance mutation M184V and/or M184I (GS-USView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Implementation science for HIV prevention using an eHealth program for Spanish-speaking sexual minorities groups in Puerto RicoView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019High prevalence of hepatitis B virus infection among chronic kidney disease patientsView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Time to treatment disfavors patients living with HIV/HCV co-infectionView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Prevalence of alcohol and substance use in a sample of patients living with HIV/HCV co-infection who are in routine clinical care receiving antiretroviral therapyView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Efficacy and safety of sofosbuvir/velpatasvir for the treatment of patients with chronic hepatitis C genotype 1-6 infection: Integrated analysis of eight Phase 3 clinical trialsView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Heterogeneity in priorities for continuing education training among clinicians providing (or not!) HIV and HCV clinical servicesView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Automated electrochemiluminescence assay could be used for screening hepatitis B and C markers in dried blood spot samples?View Abstract
